FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

425508009: Sitagliptin phosphate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2661573010 Sitagliptin phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2675154010 Sitagliptin phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2661573010 Sitagliptin phosphate (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2661573010 Sitagliptin phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2675154010 Sitagliptin phosphate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2675154010 Sitagliptin phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
19261000188113 sitagliptine phosphate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
19261000188113 sitagliptine phosphate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sitagliptin phosphate (substance) Is a Sitagliptin (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Sitagliptin phosphate (substance) Has disposition Dipeptidyl peptidase IV inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Sitagliptin phosphate (substance) Is modification of (attribute) Sitagliptin (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Sitagliptin phosphate (substance) Is a Substance with dipeptidyl peptidase IV inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Sitagliptin phosphate (substance) Is a Triazole derivative false Inferred relationship Existential restriction modifier (core metadata concept)
Sitagliptin phosphate (substance) Is a Serine proteinase inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Sitagliptin phosphate (substance) Has disposition Serine proteinase inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Sitagliptin phosphate (substance) Is a Substance with triazole structure (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 500 milligram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing metformin and sitagliptin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 500 milligram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet Has precise active ingredient False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet Has precise active ingredient True Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely metformin hydrochloride 500 milligram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet Has precise active ingredient False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet Has precise active ingredient True Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Sitagliptin phosphate monohydrate (substance) Is modification of (attribute) True Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet Has precise active ingredient False Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 500 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has precise active ingredient True Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Metformin hydrochloride 850 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet Has precise active ingredient True Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Sitagliptin phosphate anhydrous Is modification of (attribute) True Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Ertugliflozin (as ertugliflozin pidolate) 5 mg and sitagliptin (as sitagliptin phosphate) 100 mg oral tablet Has precise active ingredient True Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 15 milligram and sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Sitagliptin phosphate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start